Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South
University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive
medicine at the University of South China
· Professional training at Huazhong University
of Science and Technology and Tongji
Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Is it necessary to find Chinese customer service to do third-generation test tubes overseas? Overseas third-generation test tubes, Chinese customer service test tubes, PGT-A,PGT-M, overseas test tube process, cross-border assisted reproduction, and communication risks of third-generation test tubes.
Is it necessary to find Chinese customer service to do third-generation test tubes overseas? See clearly "convenient communication" and "real key" from six judgment points
Let's get this straight: Are you looking for "Chinese customer service" or "security"?
When many people consider making third-generation test tubes overseas, their first reaction is not hospital laboratory parameters or indications for genetic testing, but a very realistic question: can someone explain the process in Chinese?
This is not a mountain out of a molehill. Assisted reproduction itself is a medical process with high information density, from initial diagnosis and evaluation, ovulation promotion scheme, egg retrieval, fertilization and embryo culture to embryo biopsy, genetic testing and transplant decision-making, each step involves professional terms, time nodes and risk notification. For cross-border medical people, language barrier is not only "trouble", but also may affect understanding, choice and cooperation. The medical system generally regards accurate communication, qualified translation and informed consent as a part of security; The NHS framework for medical translation services also clearly emphasizes that language support is directly related to patients' understanding, consent and fair access to medical services.
But the other side of the problem should also be made clear: Chinese customer service is helpful, which does not mean that the quality of medical care is higher; There is no Chinese customer service, which does not mean that it is definitely not suitable to go.
Therefore, the real question to ask is not "Do you want Chinese customer service", but:
In your case, is Chinese support a plus or a necessity?
What is the third generation test tube? Don't confuse the concept at the beginning.
In the Chinese context, "third generation test tube" usually refers to * * preimplantation genetic testing (PGT)** related technologies, that is, screening or testing embryos at the genetic level before embryo transfer. The European Society of Human Reproduction and Embryology (ESHRE) divides them into several categories: PGT-M for monogenic genetic diseases, PGT-SR for chromosomal structural abnormalities, and PGT-A for screening embryo aneuploidy.
This distinction is very important, because different types of PGT have different medical indications.
If one or both spouses are known to carry a single-gene genetic disease, PGT-M often has a clear medical use.
If there are structural abnormalities such as chromosome balanced translocation, PGT-SR will often enter the scope of clinical discussion.
However, if PGT-A is only understood as "it is easier to succeed if you do it", this cognition is not rigorous. The Committee of the American Society for Reproductive Medicine (ASRM) in 2024 pointed out that the clinical value of PGT-A as a routine screening method is still unclear, and the existing research results are inconsistent. Britain's HFEA also classified its evidence rating of improving the chance of live birth and reducing the risk of abortion as "gray", which means that the medium and high quality evidence is still insufficient.
This means: before you call Chinese customer service, you must first confirm what kind of "third-generation test tube" you are making and whether it is really of medical significance to you.
Expert tip:
PGT is a kind of technology collection, not a "package name" with unified effect. If you don't know whether you are doing PGT-M, PGT-SR or PGT-A, no matter how good the customer service is, it can only help you to make the vague question more smooth, instead of making the medical judgment right.
Who needs Chinese customer service more than "with or without"
From the perspective of process management, not everyone needs Chinese customer service equally. The following categories of people are usually more worthy of "Chinese support ability" as the core screening item.
The first category: people with complicated medical history, more data and more judgment nodes.
For example, people with repeated abortion, repeated transplant failure, chromosome abnormality, family history of hereditary diseases, different experiences in promoting ovulation, and long-term recurrent endometrial or immune problems. This kind of patients is not as simple as "going to a procedure", but needs to continue to understand why the doctor changed the plan like this, why he suggested biopsy, and why he did not transplant this cycle first. With a large amount of information, language errors are easily amplified.
The second category: people who need to deal with genetic interpretation.
PGT involves biopsy, detection platform, report interpretation, chimera processing, and the selection of transplantable embryos. ASRM's document on PGT-A mosaic embryo management also mentioned that the interpretation and clinical treatment of related results are not simple, and the test results cannot be understood mechanically.
In this case, if there is only a customer service who speaks Chinese but doesn't understand medicine, it may cause a second misunderstanding.
The third category: people who have obvious difficulties in English medical communication.
This is not a question of ability, but a question of risk. You may understand hotel, invoice, appointment, but you may not be able to accurately understand blastocyst biopsy, mosaic result, aneuploidy, freeze-all, OHSS risk, which really affect decision-making. When the language is insufficient, informed consent is easy to become a mere formality. Medical communication research generally believes that the lack of professional language support will increase the risk of misunderstanding and adverse consequences.
The fourth category: people with tight cross-border time schedule who can't try and make mistakes repeatedly.
Overseas test tubes often overlap with visa, flight, accommodation, leave, blood collection for inspection, menstrual cycle coordination and other issues. For this kind of people, the meaning of Chinese customer service is not just "translation", but to explain the process nodes in advance to reduce the time loss caused by misunderstanding.
So the conclusion is clear:
If you can only use English for daily communication and your illness is relatively simple, Chinese customer service is a convenient item.
If you are involved in complex medical history, genetic decision-making or cross-border multi-link coordination, Chinese customer service is closer to the necessary items.
What the technical level should really focus on is not "can you speak Chinese", but these four things.
Many people will be attracted by "being accompanied by Chinese all the time", but from the first principle, the core of assisted reproduction results is still determined by medical judgment and laboratory ability, not by language packaging.
1. Does your PGT have clear medical indications?
This is number one. Because if the indication itself is not sufficient and the communication is smooth, it will only be more successful in doing something with unreliable evidence. Both ASRM and HFEA's attitude towards PGT-A reminds us that it can't be regarded as a conventional synergistic tool for everyone.
2. Is the embryo laboratory and biopsy process standardized?
ESHRE's PGT proposal specifically covers tissue management, embryo biopsy and sample processing, which shows that it is the experimental process, sample identification, laboratory collaboration and quality control, not the propaganda caliber, that really affects the reliability of the results.
3. Did the doctor explain the benefits and limitations clearly?
Reliable communication will not only talk about "screening is more reassuring", but also talk about limitations, false positive and false negative risks, difficulties in chimera interpretation, the possibility that there are no transplantable embryos, and the income is not consistent at different ages and different causes. ASRM 2024 clearly points out that the value of PGT-A as a universal screening has not been established.
4. Does the transplantation strategy restrain, rather than cater to anxiety?
Many cross-border patients worry about time and cost, and tend to transplant multiple embryos at once. However, the risk of multiple pregnancy has always been an important issue in assisted reproduction. According to the monitoring data of ART in CDC, ART is closely related to the risk of multiple births, so modern assisted reproduction pays more and more attention to reducing unnecessary multiple embryo transfer.
Expert tip:
Chinese customer service can improve the efficiency of understanding, but it cannot replace genetic counseling, doctor's face-to-face consultation and standardized informed consent. What should be confirmed first is whether you have clear medical indications, whether the laboratory is standardized, and whether the doctor is willing to explain the restrictions.
In the real process, what can Chinese customer service solve and what it can't?
Many people think that Chinese customer service is too versatile, which will lead to judgment bias.
Chinese customer service can usually solve these problems:
Help you with the preliminary data collection and appointment docking.
Help you understand the basic process and schedule.
Assist you with non-medical affairs such as checklists, visas, accommodation, transportation, etc.
Assist in translation on the day of consultation to improve the efficiency of consultation.
Help you understand the general idea of the report and the next step.
But Chinese customer service usually can't solve these problems for you:
Can't make treatment decisions instead of doctors.
Can not replace professional genetic counseling to explain complex test results.
You can't turn the technology with insufficient evidence into "suitable for you"
You can't reduce the risk of medical complications just because you speak Chinese.
An institution with a smooth process cannot be automatically equated with a high-level reproductive center.
In other words, Chinese customer service is "communication infrastructure", not "medical outcome insurance".
This is why experienced people will not only ask "Is there a Chinese service" when screening institutions, but will continue to ask:
Is Chinese customer service fixed for a long time or outsourced temporarily?
Can you translate medical terms, or just be a receptionist?
When communicating critically, do doctors communicate directly, or do they rely entirely on customer service?
Is there an official translation of the informed consent document?
After the test report comes out, will genetic counseling be arranged?
These questions are more valuable than "whether there is Chinese customer service" itself.
Frequently asked questions: Is it necessary? Look at these four realistic questions and answers
Question 1: English is ok. Is it unnecessary to find Chinese customer service?
Not necessarily. Life English and medical English are not the same thing. * * If your treatment path is simple and you only do basic IVF, and the hospital can provide written instructions, you may not have to rely on Chinese customer service. However, if it involves PGT report interpretation, scheme adjustment or cross-border multi-link arrangement, Chinese support still has obvious value.
Question 2: Does having Chinese customer service mean that this hospital is more suitable for patients in China?
You can't infer it directly. Chinese service shows that the other party attaches importance to the Chinese user experience, but * * does not mean that laboratories, doctors and genetic testing systems are stronger. * * Medical ability should still be judged by qualification, indication management, laboratory process and informed consent quality.
Question 3: Which is more important, Chinese customer service or genetic counseling, to make three generations of test tubes?
If sequencing is necessary, genetic counseling is more important. * * Because the core of PGT is not "whether to do it or not", but "why to do it, what kind to do it, and how to interpret the results". Customer service can help you understand the process, but it can't replace the professional explanation at the genetic level.
Question 4: In order to save money, can we not find Chinese customer service?
Yes, but only if you can complete high-quality communication yourself. Otherwise, you may save only superficial costs, and what you pay later may be misunderstandings, omissions, delays, and even false expectations. The emphasis on professional translation in the medical field is essentially to reduce the risk caused by communication deviation.
Summary: What is really necessary is not "Chinese customer service" itself, but "low error communication ability"
Back to the question at the beginning: Is it necessary to find Chinese customer service to do the third generation test tube overseas?
The objective answer is:
For some people, it is necessary; But it is not the core variable that determines success or failure.
If your situation involves genetic disease screening, complicated medical history, cross-border coordination and obvious obstacles in medical English, then Chinese customer service can significantly improve understanding efficiency and process stability, and this value is real.
However, if Chinese customer service is regarded as a substitute index of hospital level, or "full Chinese" is understood as "more suitable for making three generations of test tubes", this judgment is biased.
A more prudent decision-making order should be:
First confirm whether you really have medical indications for PGT;
Re-confirm whether the hospital can clearly explain the benefits, limitations and risks;
Finally, see if Chinese support is enough to help you complete low-error communication.
To sum up in a word: Chinese customer service is important for making three generations of test tubes overseas, but more important than Chinese is to truly understand every medical decision.
Common aliases:Kyrgyzstan Tulip Reproductive Center, Tulip IVF, Tulip Reproductive Center, Tulip Hospital, Kyrgyz Tulip Reproductive Center, Kyrgyz Tulip Hospital
